Delving into the Latest Updates on Bei Jing Zhi Yuan Hong Sheng Sheng Wu Yi Yao You Xian Gong Si with Synapse

Overview

Tags

Nervous System Diseases

Other Diseases

Monoclonal antibody

Disease domain score

A glimpse into the focused therapeutic areas

Technology Platform

Most used technologies in drug development

Targets

Most frequently developed targets

No Data

Disease Domain	Count

Nervous System Diseases	1

Top 5 Drug Type	Count

Monoclonal antibody	1

Primary objective: To evaluate the safety and tolerability of a single intravenous infusion of AA001 monoclonal antibody in healthy adult participants. Secondary objectives: 1) To evaluate the pharmacokinetic characteristics of a single intravenous infusion of AA001 monoclonal antibody in healthy adult participants; 2) To evaluate the immunogenicity of a single intravenous infusion of AA001 monoclonal antibody in healthy adult participants.

Start Date-

Sponsor / Collaborator

Bei Jing Zhi Yuan Hong Sheng Sheng Wu Yi Yao You Xian Gong Si

100 Clinical Results associated with Bei Jing Zhi Yuan Hong Sheng Sheng Wu Yi Yao You Xian Gong Si

Login to view more data

0 Patents (Medical) associated with Bei Jing Zhi Yuan Hong Sheng Sheng Wu Yi Yao You Xian Gong Si

Login to view more data

100 Deals associated with Bei Jing Zhi Yuan Hong Sheng Sheng Wu Yi Yao You Xian Gong Si

Login to view more data

100 Translational Medicine associated with Bei Jing Zhi Yuan Hong Sheng Sheng Wu Yi Yao You Xian Gong Si

Login to view more data

Corporation Tree

Boost your research with our corporation tree data.

login

or

view full example data

Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 18 Jun 2025

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

Phase 1 Clinical

1

Login to view more data